美股市场个股详情
WST West Pharmaceutical Services
- 318.750
- +7.090+2.27%
交易中 11/21 14:35 (美东)
230.85亿总市值47.29市盈率TTM
318.770最高价308.455最低价20.85万股成交量313.830今开311.660昨收6558.65万成交额0.29%换手率40.45市盈率(静)7242.23万总股本412.98952周最高8.39市净率229.26亿流通值264.61252周最低0.80股息TTM7192.36万流通股471.827历史最高0.25%股息率TTM3.31%振幅2.978历史最低314.628平均价1股每手
关于West Pharmaceutical Services公司
西氏医药服务公司生产和销售药品、生物制剂、疫苗和消费者保健产品。它通过以下业务部门运作:专有产品和合同制造产品。专利产品部门为生物、仿制药和制药药物客户提供专利包装、密封和药物输送产品，以及分析实验室服务。合同制造产品部门是一个完全集成的业务，专注于复杂设备的设计、制造和自动化组装，主要面向制药、诊断和医疗设备客户。
公司介绍
公司代码WST
公司名称West Pharmaceutical Services
上市日期1982/06/01
发行价格16.00
成立日期1923
CEOMr. Eric Mark Green
所属市场纽交所
员工数量10600
年结日12-31
公司地址530 Herman O. West Drive
城市Exton
省份宾夕法尼亚州
国家美国
邮编19341-0645
电话1-610-594-2900
董事高管
- 姓名
- 职务
- 年薪
- Eric Mark Green
- Chief Executive Officer, President and Chairman of the Board
- 939.59万
- Annette F. Favorite
- Senior Vice President and Chief Human Resources Officer
- --
- Silji Abraham
- Senior Vice President and Chief Technology Officer
- 167.22万
- Cindy Reiss-Clark
- Chief Commercial Officer
- 152.97万
- Chad R. Winters
- Vice President, Chief Accounting Officer and Corporate Controller
- --
- Bernard J. Birkett
- Senior Vice President, Chief Financial and Operations Officer
- 363.70万
- Quintin J. Lai
- Vice President, Strategy and Investor Relations
- --
- Kimberly Banks MacKay
- Senior Vice President, General Counsel and Corporate Secretary
- 149.17万
- Paolo Pucci
- Lead Independent Director
- 36.74万
- Douglas A. Michels
- Independent Director
- 37.70万
- Dr. Myla P. Lai-Goldman,M.D.
- Independent Director
- 35.93万
- Mark A. Buthman
- Independent Director
- 37.82万
- Dr. William F. Feehery, PhD
- Independent Director
- 36.28万
- Molly E. Joseph
- Independent Director
- 32.14万
- Thomas W. Hofmann
- Independent Director
- 39.03万
- Dr. Stephen H. Lockhart, PhD
- Independent Director
- 33.15万
- Robert F. Friel
- Independent Director
- 33.07万
- Deborah L.V. Keller
- Independent Director
- 33.35万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据